Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Ochronosis | 2 | 2021 | 7 | 1.530 |
Why?
|
Alkaptonuria | 2 | 2021 | 13 | 1.520 |
Why?
|
Histiocytosis | 2 | 2020 | 39 | 1.120 |
Why?
|
Skin Neoplasms | 24 | 2022 | 5849 | 1.010 |
Why?
|
Keratosis, Seborrheic | 1 | 2022 | 31 | 0.800 |
Why?
|
Cellulitis | 2 | 2020 | 206 | 0.730 |
Why?
|
Liver Diseases, Alcoholic | 12 | 1999 | 157 | 0.680 |
Why?
|
Histiocytes | 1 | 2020 | 95 | 0.670 |
Why?
|
Sarcoma, Kaposi | 5 | 2006 | 375 | 0.670 |
Why?
|
Nevus | 4 | 2012 | 205 | 0.650 |
Why?
|
Melanocytes | 4 | 2015 | 515 | 0.550 |
Why?
|
Carcinoma, Squamous Cell | 6 | 2022 | 4044 | 0.530 |
Why?
|
Lymphatic Vessels | 1 | 2020 | 355 | 0.510 |
Why?
|
Melanoma | 12 | 2015 | 5719 | 0.440 |
Why?
|
Skin | 10 | 2021 | 4489 | 0.390 |
Why?
|
Lip Neoplasms | 3 | 1998 | 36 | 0.390 |
Why?
|
Lymphatic Diseases | 1 | 2013 | 317 | 0.390 |
Why?
|
Nevus, Pigmented | 2 | 2015 | 227 | 0.380 |
Why?
|
Skin Aging | 2 | 2012 | 140 | 0.370 |
Why?
|
Lasers, Gas | 1 | 2012 | 103 | 0.360 |
Why?
|
Immunohistochemistry | 17 | 2020 | 11022 | 0.350 |
Why?
|
Carcinoma, Basal Cell | 4 | 2011 | 566 | 0.340 |
Why?
|
Lasers, Solid-State | 1 | 2012 | 183 | 0.340 |
Why?
|
Receptor, Nerve Growth Factor | 1 | 2009 | 48 | 0.330 |
Why?
|
Wound Healing | 1 | 2020 | 2792 | 0.320 |
Why?
|
Lupus Erythematosus, Cutaneous | 1 | 2010 | 80 | 0.310 |
Why?
|
Ki-67 Antigen | 2 | 2009 | 629 | 0.310 |
Why?
|
Terminology as Topic | 2 | 2012 | 1534 | 0.290 |
Why?
|
Acquired Immunodeficiency Syndrome | 3 | 2006 | 2203 | 0.270 |
Why?
|
Laser Therapy | 2 | 2012 | 1108 | 0.270 |
Why?
|
Shoulder Joint | 1 | 2013 | 740 | 0.270 |
Why?
|
Herpesvirus 8, Human | 2 | 2005 | 254 | 0.270 |
Why?
|
Face | 1 | 2012 | 1028 | 0.260 |
Why?
|
Purpura | 2 | 2004 | 115 | 0.260 |
Why?
|
Osteoarthritis | 1 | 2013 | 1051 | 0.250 |
Why?
|
Epidermis | 3 | 2022 | 538 | 0.240 |
Why?
|
Acanthamoeba | 1 | 2003 | 12 | 0.230 |
Why?
|
Skin Diseases, Parasitic | 1 | 2003 | 14 | 0.220 |
Why?
|
Amebiasis | 1 | 2003 | 33 | 0.220 |
Why?
|
Necrobiosis Lipoidica | 1 | 2023 | 14 | 0.220 |
Why?
|
Scurvy | 1 | 2003 | 36 | 0.210 |
Why?
|
Palpation | 1 | 2003 | 166 | 0.210 |
Why?
|
Pigmentation | 1 | 2003 | 143 | 0.210 |
Why?
|
Fibroadenoma | 1 | 2002 | 40 | 0.200 |
Why?
|
Cystadenoma | 1 | 2002 | 76 | 0.200 |
Why?
|
Proto-Oncogene Proteins c-kit | 2 | 2005 | 723 | 0.200 |
Why?
|
Thromboxane B2 | 4 | 1997 | 143 | 0.190 |
Why?
|
Diagnosis, Differential | 12 | 2020 | 12976 | 0.190 |
Why?
|
Hydroquinones | 1 | 2021 | 34 | 0.190 |
Why?
|
Proliferating Cell Nuclear Antigen | 5 | 1996 | 284 | 0.180 |
Why?
|
Eyelid Neoplasms | 1 | 2002 | 84 | 0.180 |
Why?
|
Foot Diseases | 2 | 2019 | 147 | 0.180 |
Why?
|
Isothiocyanates | 1 | 2020 | 48 | 0.170 |
Why?
|
Drug Eruptions | 2 | 2014 | 335 | 0.170 |
Why?
|
Biopsy | 8 | 2020 | 6763 | 0.170 |
Why?
|
S100 Proteins | 2 | 1998 | 217 | 0.170 |
Why?
|
Disaccharides | 1 | 2020 | 170 | 0.160 |
Why?
|
Rats, Wistar | 14 | 1999 | 1884 | 0.160 |
Why?
|
Melanoma, Amelanotic | 1 | 2019 | 19 | 0.160 |
Why?
|
Carcinoma | 4 | 2020 | 2312 | 0.160 |
Why?
|
Keratoacanthoma | 1 | 1999 | 33 | 0.160 |
Why?
|
Prototheca | 1 | 1998 | 3 | 0.160 |
Why?
|
Lupus Erythematosus, Systemic | 3 | 2010 | 2159 | 0.150 |
Why?
|
Erythema | 1 | 2020 | 262 | 0.150 |
Why?
|
Neoplastic Stem Cells | 1 | 2006 | 1352 | 0.150 |
Why?
|
Cimetidine | 2 | 1996 | 76 | 0.150 |
Why?
|
Pathology | 1 | 2021 | 270 | 0.150 |
Why?
|
Viral Proteins | 1 | 2005 | 1797 | 0.150 |
Why?
|
Skin Diseases, Infectious | 1 | 1998 | 73 | 0.150 |
Why?
|
Neoplasm Invasiveness | 6 | 2014 | 3602 | 0.140 |
Why?
|
Multiple Endocrine Neoplasia Type 1 | 1 | 2017 | 43 | 0.140 |
Why?
|
Tissue Fixation | 2 | 2015 | 244 | 0.140 |
Why?
|
Thromboxane A2 | 1 | 1997 | 87 | 0.140 |
Why?
|
Thyroid Gland | 1 | 2003 | 1180 | 0.130 |
Why?
|
Interferon-alpha | 3 | 2019 | 910 | 0.130 |
Why?
|
Abdominal Wall | 1 | 2018 | 166 | 0.130 |
Why?
|
Humans | 69 | 2023 | 765968 | 0.130 |
Why?
|
Benzoquinones | 1 | 1996 | 198 | 0.130 |
Why?
|
Propionates | 1 | 1996 | 180 | 0.130 |
Why?
|
Fibroma | 1 | 2017 | 197 | 0.130 |
Why?
|
Nail Diseases | 1 | 2016 | 54 | 0.120 |
Why?
|
Exanthema | 1 | 2020 | 502 | 0.120 |
Why?
|
Toxemia | 1 | 1995 | 14 | 0.120 |
Why?
|
Nucleolus Organizer Region | 1 | 1995 | 25 | 0.120 |
Why?
|
Paget's Disease, Mammary | 1 | 1995 | 18 | 0.120 |
Why?
|
Transforming Growth Factor beta | 3 | 1997 | 1995 | 0.120 |
Why?
|
Liver | 12 | 2000 | 7562 | 0.120 |
Why?
|
Nuclear Proteins | 5 | 2005 | 5783 | 0.120 |
Why?
|
Carcinoma, Lobular | 1 | 1998 | 471 | 0.110 |
Why?
|
Neoplasms, Glandular and Epithelial | 1 | 2018 | 488 | 0.110 |
Why?
|
Leg Ulcer | 1 | 2014 | 70 | 0.110 |
Why?
|
Onycholysis | 1 | 2013 | 3 | 0.110 |
Why?
|
Epidermolysis Bullosa Acquisita | 1 | 2013 | 15 | 0.110 |
Why?
|
Hamartoma | 2 | 1993 | 233 | 0.110 |
Why?
|
Hemangiosarcoma | 2 | 1995 | 211 | 0.100 |
Why?
|
Nipples | 1 | 1995 | 222 | 0.100 |
Why?
|
Mucormycosis | 1 | 2014 | 104 | 0.100 |
Why?
|
Carcinoma in Situ | 1 | 1998 | 779 | 0.100 |
Why?
|
Facial Neoplasms | 2 | 2004 | 127 | 0.100 |
Why?
|
Ethanol | 3 | 1997 | 1323 | 0.100 |
Why?
|
Livedo Reticularis | 1 | 2011 | 5 | 0.090 |
Why?
|
Dermatology | 1 | 2021 | 907 | 0.090 |
Why?
|
Male | 47 | 2020 | 363698 | 0.090 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 1995 | 1132 | 0.090 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 1998 | 1083 | 0.090 |
Why?
|
Scalp | 2 | 1993 | 388 | 0.090 |
Why?
|
Opportunistic Infections | 1 | 2014 | 376 | 0.090 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 1995 | 540 | 0.090 |
Why?
|
Trichotillomania | 1 | 1992 | 178 | 0.090 |
Why?
|
Middle Aged | 27 | 2020 | 223009 | 0.090 |
Why?
|
Rats | 17 | 1999 | 23707 | 0.090 |
Why?
|
Ectoparasitic Infestations | 1 | 2009 | 12 | 0.090 |
Why?
|
Single-Blind Method | 2 | 2012 | 1589 | 0.080 |
Why?
|
Xanthogranuloma, Juvenile | 1 | 1989 | 17 | 0.080 |
Why?
|
Ixodes | 1 | 2009 | 41 | 0.080 |
Why?
|
Ecthyma, Contagious | 1 | 2009 | 1 | 0.080 |
Why?
|
Calcinosis | 1 | 1998 | 1479 | 0.080 |
Why?
|
Immunocompromised Host | 2 | 2014 | 866 | 0.080 |
Why?
|
HIV | 2 | 2008 | 1585 | 0.080 |
Why?
|
Photography | 1 | 2012 | 533 | 0.080 |
Why?
|
Bites and Stings | 1 | 2009 | 95 | 0.080 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2023 | 3446 | 0.080 |
Why?
|
Islam | 1 | 2009 | 72 | 0.080 |
Why?
|
Amyloidosis | 1 | 2016 | 885 | 0.070 |
Why?
|
Cholesterol | 1 | 1997 | 2898 | 0.070 |
Why?
|
Tumor Necrosis Factor-alpha | 3 | 1997 | 4348 | 0.070 |
Why?
|
Darier Disease | 1 | 1987 | 13 | 0.070 |
Why?
|
Neoplasm Metastasis | 1 | 1998 | 4893 | 0.070 |
Why?
|
AIDS-Related Opportunistic Infections | 2 | 2004 | 664 | 0.070 |
Why?
|
Sweet Syndrome | 1 | 2008 | 59 | 0.070 |
Why?
|
Oligopeptides | 1 | 2013 | 1192 | 0.070 |
Why?
|
Dendritic Cells | 1 | 1998 | 2747 | 0.070 |
Why?
|
Immunoenzyme Techniques | 2 | 2004 | 1701 | 0.070 |
Why?
|
Neoplasms, Second Primary | 1 | 1995 | 1050 | 0.070 |
Why?
|
Fetal Proteins | 1 | 2006 | 99 | 0.070 |
Why?
|
Prostaglandin-Endoperoxide Synthases | 2 | 1997 | 318 | 0.070 |
Why?
|
Neoplasm Recurrence, Local | 4 | 2019 | 9373 | 0.070 |
Why?
|
Liver Cirrhosis, Alcoholic | 2 | 1997 | 64 | 0.070 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 1 | 1993 | 920 | 0.060 |
Why?
|
RNA, Messenger | 5 | 1997 | 12768 | 0.060 |
Why?
|
Intestines | 1 | 1995 | 1906 | 0.060 |
Why?
|
Intermediate Filament Proteins | 1 | 2006 | 261 | 0.060 |
Why?
|
Syphilis | 1 | 2008 | 243 | 0.060 |
Why?
|
Antigens, Neoplasm | 1 | 1993 | 2002 | 0.060 |
Why?
|
Female | 26 | 2020 | 396112 | 0.060 |
Why?
|
Cell Adhesion Molecules, Neuronal | 1 | 2006 | 262 | 0.060 |
Why?
|
Endothelium | 3 | 1996 | 767 | 0.060 |
Why?
|
Proto-Oncogene Proteins | 1 | 2017 | 4520 | 0.060 |
Why?
|
Tissue Array Analysis | 1 | 2006 | 545 | 0.060 |
Why?
|
Breast Neoplasms | 4 | 1998 | 21056 | 0.060 |
Why?
|
Neovascularization, Pathologic | 1 | 1995 | 2631 | 0.060 |
Why?
|
Antigens, CD | 3 | 2008 | 4025 | 0.060 |
Why?
|
Analysis of Variance | 2 | 2012 | 6203 | 0.060 |
Why?
|
Sulbactam | 1 | 2004 | 32 | 0.060 |
Why?
|
Ampicillin | 1 | 2004 | 138 | 0.060 |
Why?
|
Matrix Metalloproteinases | 1 | 2006 | 392 | 0.060 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2014 | 2054 | 0.060 |
Why?
|
Pentamidine | 1 | 2003 | 44 | 0.060 |
Why?
|
Biopsy, Needle | 3 | 2014 | 1628 | 0.060 |
Why?
|
Cell Differentiation | 2 | 2020 | 11641 | 0.060 |
Why?
|
Itraconazole | 1 | 2003 | 42 | 0.060 |
Why?
|
Tetracyclines | 1 | 2004 | 64 | 0.050 |
Why?
|
Antiparasitic Agents | 1 | 2003 | 41 | 0.050 |
Why?
|
Adult | 20 | 2018 | 223044 | 0.050 |
Why?
|
Skin Diseases, Vesiculobullous | 1 | 2004 | 84 | 0.050 |
Why?
|
Necrosis | 3 | 2014 | 1617 | 0.050 |
Why?
|
Receptor, trkC | 1 | 2003 | 63 | 0.050 |
Why?
|
Antiprotozoal Agents | 1 | 2003 | 93 | 0.050 |
Why?
|
Pigmentation Disorders | 1 | 2004 | 106 | 0.050 |
Why?
|
Skin Diseases | 2 | 2021 | 1088 | 0.050 |
Why?
|
Protein Precursors | 1 | 1987 | 1134 | 0.050 |
Why?
|
Cysts | 2 | 2002 | 684 | 0.050 |
Why?
|
Neoplasm Proteins | 1 | 1995 | 3596 | 0.050 |
Why?
|
Isoenzymes | 2 | 1997 | 1689 | 0.050 |
Why?
|
Hidrocystoma | 1 | 2002 | 10 | 0.050 |
Why?
|
Hepatitis C | 1 | 2013 | 1597 | 0.050 |
Why?
|
Lipid Peroxidation | 4 | 1997 | 275 | 0.050 |
Why?
|
HIV Infections | 2 | 2008 | 17533 | 0.050 |
Why?
|
Minocycline | 1 | 2003 | 168 | 0.050 |
Why?
|
Color | 1 | 2003 | 299 | 0.050 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2006 | 2844 | 0.050 |
Why?
|
Dermatitis | 1 | 2004 | 199 | 0.050 |
Why?
|
Fish Oils | 2 | 1996 | 483 | 0.050 |
Why?
|
Crohn Disease | 2 | 2013 | 2283 | 0.050 |
Why?
|
Thoracic Wall | 1 | 2003 | 197 | 0.050 |
Why?
|
Radiation Chimera | 1 | 2001 | 216 | 0.050 |
Why?
|
Phosphoglucomutase | 1 | 2001 | 6 | 0.050 |
Why?
|
In Situ Hybridization | 1 | 2005 | 1886 | 0.050 |
Why?
|
Chronic Disease | 3 | 2010 | 9347 | 0.050 |
Why?
|
Remission Induction | 2 | 2004 | 2411 | 0.050 |
Why?
|
Ovarian Neoplasms | 1 | 2018 | 4900 | 0.040 |
Why?
|
Sweat Gland Neoplasms | 1 | 2002 | 110 | 0.040 |
Why?
|
Dietary Fats | 3 | 1997 | 2002 | 0.040 |
Why?
|
Injections, Subcutaneous | 1 | 2002 | 682 | 0.040 |
Why?
|
Giant Cells | 1 | 2001 | 187 | 0.040 |
Why?
|
Antiviral Agents | 1 | 2013 | 3050 | 0.040 |
Why?
|
Bone Marrow Transplantation | 2 | 2014 | 2729 | 0.040 |
Why?
|
Aged | 10 | 2020 | 171117 | 0.040 |
Why?
|
Treatment Outcome | 6 | 2014 | 65188 | 0.040 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2004 | 616 | 0.040 |
Why?
|
Granuloma | 1 | 2002 | 327 | 0.040 |
Why?
|
Patient Satisfaction | 1 | 2012 | 3475 | 0.040 |
Why?
|
Corn Oil | 2 | 1996 | 30 | 0.040 |
Why?
|
Aged, 80 and over | 7 | 2014 | 59489 | 0.040 |
Why?
|
Pyoderma Gangrenosum | 1 | 2001 | 86 | 0.040 |
Why?
|
Prognosis | 6 | 2006 | 29922 | 0.040 |
Why?
|
Lymphocyte Depletion | 1 | 2001 | 605 | 0.040 |
Why?
|
Animals | 21 | 2009 | 168764 | 0.040 |
Why?
|
Acute Disease | 1 | 2010 | 7232 | 0.040 |
Why?
|
Isoantigens | 1 | 2001 | 562 | 0.040 |
Why?
|
Glycoproteins | 1 | 2006 | 2195 | 0.040 |
Why?
|
Immunophenotyping | 1 | 2004 | 1866 | 0.040 |
Why?
|
Severity of Illness Index | 2 | 2013 | 15880 | 0.040 |
Why?
|
Phosphoproteins | 2 | 2005 | 2446 | 0.040 |
Why?
|
Sampling Studies | 2 | 2014 | 607 | 0.040 |
Why?
|
DNA, Viral | 1 | 2005 | 2199 | 0.040 |
Why?
|
Microscopy, Confocal | 1 | 2004 | 1966 | 0.040 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2002 | 587 | 0.040 |
Why?
|
Carcinoma, Verrucous | 1 | 1998 | 27 | 0.040 |
Why?
|
Multiple Myeloma | 1 | 2016 | 5197 | 0.040 |
Why?
|
Sensitivity and Specificity | 3 | 2015 | 14652 | 0.040 |
Why?
|
Thromboxane-A Synthase | 1 | 1997 | 34 | 0.040 |
Why?
|
Antibodies, Monoclonal | 1 | 1995 | 9249 | 0.040 |
Why?
|
Receptors, Thromboxane | 1 | 1997 | 30 | 0.040 |
Why?
|
Dinoprost | 2 | 1996 | 139 | 0.040 |
Why?
|
Up-Regulation | 1 | 2006 | 4137 | 0.040 |
Why?
|
Lymph Nodes | 2 | 2008 | 3454 | 0.040 |
Why?
|
Inflammation | 1 | 1997 | 10850 | 0.040 |
Why?
|
Skin Diseases, Viral | 1 | 1997 | 25 | 0.040 |
Why?
|
Adenocarcinoma | 1 | 1995 | 6364 | 0.030 |
Why?
|
Pain | 1 | 2012 | 5077 | 0.030 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 1 | 1998 | 281 | 0.030 |
Why?
|
Fatty Liver, Alcoholic | 1 | 1997 | 36 | 0.030 |
Why?
|
Sentinel Lymph Node Biopsy | 2 | 2014 | 728 | 0.030 |
Why?
|
Transforming Growth Factor alpha | 1 | 1997 | 134 | 0.030 |
Why?
|
Cell Division | 4 | 1996 | 4475 | 0.030 |
Why?
|
Soft Tissue Infections | 1 | 1998 | 167 | 0.030 |
Why?
|
Paclitaxel | 1 | 2004 | 1728 | 0.030 |
Why?
|
Protein Deficiency | 1 | 1996 | 57 | 0.030 |
Why?
|
S Phase | 2 | 1994 | 424 | 0.030 |
Why?
|
Polymerase Chain Reaction | 1 | 2005 | 6069 | 0.030 |
Why?
|
Antigens, CD1 | 1 | 1998 | 435 | 0.030 |
Why?
|
Arm | 1 | 1999 | 589 | 0.030 |
Why?
|
Stereotaxic Techniques | 1 | 1998 | 551 | 0.030 |
Why?
|
Transplantation, Homologous | 2 | 2001 | 4860 | 0.030 |
Why?
|
Oxazoles | 1 | 1997 | 198 | 0.030 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2004 | 2423 | 0.030 |
Why?
|
Hepatitis B, Chronic | 1 | 2000 | 412 | 0.030 |
Why?
|
Antineoplastic Agents | 2 | 2011 | 13648 | 0.030 |
Why?
|
Mastectomy, Simple | 1 | 1995 | 23 | 0.030 |
Why?
|
Cytochrome P-450 Enzyme System | 2 | 1994 | 423 | 0.030 |
Why?
|
Histocytological Preparation Techniques | 1 | 1995 | 31 | 0.030 |
Why?
|
Hutchinson's Melanotic Freckle | 1 | 1995 | 26 | 0.030 |
Why?
|
Dysplastic Nevus Syndrome | 1 | 1995 | 60 | 0.030 |
Why?
|
Animal Feed | 1 | 1995 | 106 | 0.030 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2015 | 4562 | 0.030 |
Why?
|
Peptides | 1 | 2006 | 4331 | 0.030 |
Why?
|
Herpes Zoster | 1 | 1997 | 252 | 0.030 |
Why?
|
Cell Count | 1 | 1998 | 1823 | 0.030 |
Why?
|
Clobetasol | 1 | 2014 | 33 | 0.030 |
Why?
|
Oxidoreductases, N-Demethylating | 1 | 1994 | 110 | 0.030 |
Why?
|
Piperazines | 1 | 2004 | 2549 | 0.030 |
Why?
|
Paraffin Embedding | 1 | 2015 | 301 | 0.030 |
Why?
|
Cell Proliferation | 1 | 2009 | 10429 | 0.030 |
Why?
|
Nerve Tissue Proteins | 1 | 2006 | 4392 | 0.030 |
Why?
|
Neoplasms, Connective Tissue | 1 | 1994 | 36 | 0.030 |
Why?
|
Arachidonic Acids | 1 | 1994 | 293 | 0.030 |
Why?
|
Axilla | 2 | 1993 | 615 | 0.030 |
Why?
|
Drug Therapy, Combination | 1 | 2003 | 6309 | 0.030 |
Why?
|
T-Lymphocyte Subsets | 1 | 2001 | 1811 | 0.030 |
Why?
|
Formaldehyde | 1 | 1995 | 352 | 0.030 |
Why?
|
G1 Phase | 1 | 1994 | 403 | 0.030 |
Why?
|
Neoplasm Staging | 4 | 2014 | 11206 | 0.030 |
Why?
|
Sebaceous Gland Neoplasms | 1 | 1993 | 38 | 0.030 |
Why?
|
Hyaluronic Acid | 1 | 1996 | 484 | 0.020 |
Why?
|
Oximes | 1 | 2014 | 305 | 0.020 |
Why?
|
Pyrimidines | 1 | 2004 | 3047 | 0.020 |
Why?
|
Immune Tolerance | 1 | 2001 | 2324 | 0.020 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 1997 | 1167 | 0.020 |
Why?
|
Killer Cells, Natural | 1 | 2001 | 2210 | 0.020 |
Why?
|
Hematopoiesis | 1 | 2001 | 2058 | 0.020 |
Why?
|
Administration, Cutaneous | 1 | 2014 | 715 | 0.020 |
Why?
|
Anti-Bacterial Agents | 3 | 2008 | 7478 | 0.020 |
Why?
|
Hepatitis C, Chronic | 1 | 2000 | 1032 | 0.020 |
Why?
|
Follow-Up Studies | 5 | 2014 | 39193 | 0.020 |
Why?
|
Pyrimidinones | 1 | 2014 | 384 | 0.020 |
Why?
|
NF-kappa B | 1 | 1999 | 2485 | 0.020 |
Why?
|
Dietary Proteins | 1 | 1996 | 959 | 0.020 |
Why?
|
Dermoscopy | 1 | 2011 | 73 | 0.020 |
Why?
|
Stevens-Johnson Syndrome | 1 | 2013 | 231 | 0.020 |
Why?
|
Cell Cycle | 2 | 1996 | 2920 | 0.020 |
Why?
|
Fatty Acids | 1 | 1997 | 1806 | 0.020 |
Why?
|
Cytokines | 2 | 2008 | 7421 | 0.020 |
Why?
|
Intestine, Small | 1 | 1996 | 1214 | 0.020 |
Why?
|
Immunologic Factors | 1 | 2019 | 1587 | 0.020 |
Why?
|
Tick-Borne Diseases | 1 | 2009 | 37 | 0.020 |
Why?
|
Carcinoma, Neuroendocrine | 1 | 1993 | 341 | 0.020 |
Why?
|
Ileal Neoplasms | 1 | 1989 | 20 | 0.020 |
Why?
|
Hair Follicle | 1 | 2011 | 224 | 0.020 |
Why?
|
Pyridones | 1 | 2014 | 816 | 0.020 |
Why?
|
Remission, Spontaneous | 1 | 2009 | 386 | 0.020 |
Why?
|
Middle East | 1 | 2009 | 237 | 0.020 |
Why?
|
Administration, Oral | 2 | 2008 | 4015 | 0.020 |
Why?
|
Protein Kinase Inhibitors | 1 | 2004 | 5696 | 0.020 |
Why?
|
Treponema pallidum | 1 | 2008 | 48 | 0.020 |
Why?
|
Colon | 1 | 1996 | 1795 | 0.020 |
Why?
|
Imidazoles | 1 | 2014 | 1162 | 0.020 |
Why?
|
Immunoelectrophoresis | 1 | 1987 | 94 | 0.020 |
Why?
|
Pregnancy | 1 | 2009 | 30260 | 0.020 |
Why?
|
Liver Transplantation | 1 | 2000 | 2412 | 0.020 |
Why?
|
Survival Analysis | 3 | 2000 | 10070 | 0.020 |
Why?
|
Tumor Suppressor Proteins | 1 | 2017 | 2796 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 2 | 1996 | 8102 | 0.020 |
Why?
|
Thumb | 1 | 2009 | 233 | 0.020 |
Why?
|
Erythema Nodosum | 1 | 1986 | 32 | 0.020 |
Why?
|
Angiomatosis | 1 | 1986 | 45 | 0.020 |
Why?
|
Chromatography, Gel | 1 | 1987 | 629 | 0.020 |
Why?
|
Liver Cirrhosis | 1 | 1997 | 1959 | 0.020 |
Why?
|
Photosensitivity Disorders | 1 | 1986 | 80 | 0.020 |
Why?
|
Injections, Intramuscular | 1 | 2008 | 552 | 0.020 |
Why?
|
Nitric Oxide | 1 | 1995 | 2143 | 0.020 |
Why?
|
Leprosy | 1 | 1986 | 125 | 0.020 |
Why?
|
Bipolar Disorder | 1 | 2003 | 5138 | 0.020 |
Why?
|
Sheep | 1 | 2009 | 1440 | 0.020 |
Why?
|
Chromatography, Affinity | 1 | 1987 | 521 | 0.020 |
Why?
|
Lipids | 1 | 1997 | 3315 | 0.020 |
Why?
|
Polyarteritis Nodosa | 1 | 1986 | 68 | 0.020 |
Why?
|
Lupus Erythematosus, Discoid | 1 | 1986 | 61 | 0.020 |
Why?
|
Transglutaminases | 1 | 1987 | 201 | 0.020 |
Why?
|
Lower Extremity | 1 | 2014 | 1226 | 0.020 |
Why?
|
Doxycycline | 1 | 2008 | 349 | 0.020 |
Why?
|
Recurrence | 2 | 2000 | 8501 | 0.020 |
Why?
|
Endotoxins | 2 | 1999 | 516 | 0.020 |
Why?
|
Lymphatic Metastasis | 1 | 1993 | 2887 | 0.020 |
Why?
|
Molecular Weight | 1 | 1987 | 2163 | 0.010 |
Why?
|
Age Factors | 2 | 1994 | 18380 | 0.010 |
Why?
|
Cyclooxygenase 2 | 2 | 1997 | 594 | 0.010 |
Why?
|
Penicillins | 1 | 2008 | 404 | 0.010 |
Why?
|
Uterine Neoplasms | 1 | 1993 | 1421 | 0.010 |
Why?
|
Parenteral Nutrition, Total | 1 | 1985 | 304 | 0.010 |
Why?
|
Receptors, Platelet-Derived Growth Factor | 1 | 2004 | 178 | 0.010 |
Why?
|
Aminoquinolines | 1 | 2004 | 102 | 0.010 |
Why?
|
Spirituality | 1 | 2009 | 430 | 0.010 |
Why?
|
Fallopian Tube Diseases | 1 | 2004 | 60 | 0.010 |
Why?
|
Forehead | 1 | 2004 | 75 | 0.010 |
Why?
|
Base Sequence | 1 | 1995 | 12403 | 0.010 |
Why?
|
Endothelium, Vascular | 1 | 1996 | 4427 | 0.010 |
Why?
|
Sickle Cell Trait | 1 | 2004 | 86 | 0.010 |
Why?
|
Hemangioma | 1 | 1989 | 723 | 0.010 |
Why?
|
Disease Progression | 2 | 2014 | 13632 | 0.010 |
Why?
|
Stomach Neoplasms | 1 | 1994 | 1471 | 0.010 |
Why?
|
Ovarian Diseases | 1 | 2004 | 131 | 0.010 |
Why?
|
Abdominal Abscess | 1 | 2004 | 152 | 0.010 |
Why?
|
Fluorescent Antibody Technique | 1 | 1987 | 2476 | 0.010 |
Why?
|
Anemia, Hemolytic, Autoimmune | 1 | 2004 | 147 | 0.010 |
Why?
|
Molecular Targeted Therapy | 1 | 2014 | 2822 | 0.010 |
Why?
|
Suppuration | 1 | 2002 | 61 | 0.010 |
Why?
|
Alopecia | 1 | 1986 | 414 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 1995 | 17594 | 0.010 |
Why?
|
Mohs Surgery | 1 | 2004 | 219 | 0.010 |
Why?
|
Cattle | 1 | 1987 | 3801 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2011 | 6493 | 0.010 |
Why?
|
Cohort Studies | 2 | 2015 | 41649 | 0.010 |
Why?
|
Arthritis | 1 | 1986 | 677 | 0.010 |
Why?
|
Proteins | 1 | 1996 | 5995 | 0.010 |
Why?
|
Diet | 2 | 1996 | 8086 | 0.010 |
Why?
|
H-2 Antigens | 1 | 2001 | 359 | 0.010 |
Why?
|
Pruritus | 1 | 2004 | 378 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2009 | 6220 | 0.010 |
Why?
|
Leukocyte Count | 1 | 2004 | 1602 | 0.010 |
Why?
|
Sunlight | 1 | 2002 | 337 | 0.010 |
Why?
|
Sex Factors | 1 | 1994 | 10603 | 0.010 |
Why?
|
Macrophages | 1 | 1995 | 5772 | 0.010 |
Why?
|
Lipid Peroxides | 1 | 1999 | 73 | 0.010 |
Why?
|
Survival Rate | 1 | 2014 | 12795 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2021 | 81514 | 0.010 |
Why?
|
Benzamides | 1 | 2004 | 1377 | 0.010 |
Why?
|
I-kappa B Proteins | 1 | 1999 | 209 | 0.010 |
Why?
|
Adoptive Transfer | 1 | 2001 | 827 | 0.010 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2008 | 2570 | 0.010 |
Why?
|
Risk Assessment | 2 | 2014 | 24282 | 0.010 |
Why?
|
Disease Models, Animal | 3 | 2009 | 18293 | 0.010 |
Why?
|
Thiobarbituric Acid Reactive Substances | 1 | 1997 | 45 | 0.010 |
Why?
|
Transgenes | 1 | 2001 | 1015 | 0.010 |
Why?
|
Diarrhea | 1 | 2004 | 1316 | 0.010 |
Why?
|
Hepatitis, Alcoholic | 1 | 1999 | 109 | 0.010 |
Why?
|
Carbon Dioxide | 1 | 2002 | 1137 | 0.010 |
Why?
|
Incidence | 2 | 2013 | 21480 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 1995 | 10261 | 0.010 |
Why?
|
Lymphocyte Activation | 1 | 2008 | 5501 | 0.010 |
Why?
|
Alanine Transaminase | 1 | 1999 | 607 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 1993 | 15398 | 0.010 |
Why?
|
Kupffer Cells | 1 | 1997 | 144 | 0.010 |
Why?
|
Chickenpox | 1 | 1997 | 95 | 0.010 |
Why?
|
Thrombocytopenia | 1 | 2004 | 1171 | 0.010 |
Why?
|
Absorption | 1 | 1996 | 242 | 0.010 |
Why?
|
Skin Transplantation | 1 | 2001 | 1098 | 0.010 |
Why?
|
NADPH Dehydrogenase | 1 | 1995 | 43 | 0.010 |
Why?
|
Endotoxemia | 1 | 1997 | 198 | 0.010 |
Why?
|
Mice | 3 | 2009 | 81819 | 0.010 |
Why?
|
Chemokines | 1 | 1999 | 956 | 0.010 |
Why?
|
Vimentin | 1 | 1996 | 258 | 0.010 |
Why?
|
NG-Nitroarginine Methyl Ester | 1 | 1995 | 261 | 0.010 |
Why?
|
Time Factors | 2 | 1995 | 40065 | 0.010 |
Why?
|
Renal Dialysis | 1 | 2004 | 1799 | 0.010 |
Why?
|
Cytochrome P-450 CYP2E1 | 1 | 1994 | 41 | 0.010 |
Why?
|
Nitrogen | 1 | 1996 | 346 | 0.010 |
Why?
|
F2-Isoprostanes | 1 | 1994 | 35 | 0.010 |
Why?
|
Fatty Acids, Unsaturated | 1 | 1997 | 538 | 0.010 |
Why?
|
Microsomes, Liver | 1 | 1994 | 174 | 0.010 |
Why?
|
Leucine | 1 | 1996 | 546 | 0.010 |
Why?
|
Enzyme Induction | 1 | 1994 | 456 | 0.010 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2004 | 3513 | 0.010 |
Why?
|
Serum Albumin | 1 | 1996 | 675 | 0.010 |
Why?
|
Immunoassay | 1 | 1996 | 741 | 0.010 |
Why?
|
Ploidies | 1 | 1992 | 287 | 0.010 |
Why?
|
von Willebrand Factor | 1 | 1996 | 676 | 0.010 |
Why?
|
Child | 2 | 2011 | 80564 | 0.010 |
Why?
|
Kidney Failure, Chronic | 1 | 2004 | 2495 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2008 | 8611 | 0.010 |
Why?
|
Intestinal Mucosa | 2 | 1996 | 3046 | 0.010 |
Why?
|
Arginine | 1 | 1995 | 933 | 0.010 |
Why?
|
Pilot Projects | 1 | 2004 | 8733 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2008 | 7851 | 0.010 |
Why?
|
Inflammation Mediators | 1 | 1999 | 1884 | 0.010 |
Why?
|
Graft Survival | 1 | 2001 | 3890 | 0.010 |
Why?
|
Down-Regulation | 1 | 1997 | 2927 | 0.010 |
Why?
|
Microscopy, Electron | 1 | 1993 | 2548 | 0.010 |
Why?
|
Laboratories, Hospital | 1 | 1991 | 193 | 0.010 |
Why?
|
Collagen | 1 | 1997 | 2618 | 0.010 |
Why?
|
Surgical Flaps | 1 | 1998 | 1677 | 0.010 |
Why?
|
Infant, Newborn | 1 | 1989 | 26346 | 0.000 |
Why?
|
Insulin-Like Growth Factor I | 1 | 1996 | 1936 | 0.000 |
Why?
|
Risk Factors | 1 | 1995 | 74840 | 0.000 |
Why?
|
Infant | 1 | 1989 | 36386 | 0.000 |
Why?
|
DNA, Neoplasm | 1 | 1992 | 1742 | 0.000 |
Why?
|
Child, Preschool | 1 | 1989 | 42500 | 0.000 |
Why?
|
Ileum | 1 | 1989 | 558 | 0.000 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2001 | 2429 | 0.000 |
Why?
|
Mice, Knockout | 1 | 2001 | 14448 | 0.000 |
Why?
|
Weight Gain | 1 | 1996 | 2355 | 0.000 |
Why?
|
Drug Stability | 1 | 1985 | 288 | 0.000 |
Why?
|
United States | 2 | 2009 | 72903 | 0.000 |
Why?
|
Mice, Inbred C57BL | 1 | 2001 | 22332 | 0.000 |
Why?
|
Kidney Transplantation | 1 | 1998 | 4270 | 0.000 |
Why?
|
DNA-Binding Proteins | 1 | 1999 | 9601 | 0.000 |
Why?
|
Flow Cytometry | 1 | 1992 | 5881 | 0.000 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 1985 | 1526 | 0.000 |
Why?
|
Signal Transduction | 1 | 2004 | 23601 | 0.000 |
Why?
|
Uterine Cervical Neoplasms | 1 | 1993 | 2047 | 0.000 |
Why?
|
Adolescent | 1 | 1989 | 88835 | 0.000 |
Why?
|
Hydrogen-Ion Concentration | 1 | 1985 | 2477 | 0.000 |
Why?
|
Massachusetts | 1 | 1991 | 8875 | 0.000 |
Why?
|
Postoperative Complications | 1 | 2000 | 15747 | 0.000 |
Why?
|
Registries | 1 | 1991 | 8297 | 0.000 |
Why?
|